Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2018-02-01 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/1/2018. It details movements in authorized and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other agreements to issue shares. The content is focused on share capital changes and movements during a specific month, with no financial statements or earnings data. This type of document is a regulatory filing reporting share capital movements to the stock exchange (Hong Kong Exchanges and Clearing Limited). It is not an earnings release, annual or interim report, or a presentation. It is also not a proxy, voting result, or management change announcement. Given the detailed share capital movement data and the monthly frequency, this fits the category of Share Issue/Capital Change (SHA). The document length is sufficient and contains substantive data on share capital changes, not just an announcement or certification. Therefore, the classification is SHA with high confidence.
2018-02-01 English
Profit Warning
Earnings Release Classification · 95% confidence The document is titled 'PROFIT WARNING' and is an announcement made pursuant to the Listing Rules and Inside Information Provisions. It provides a preliminary assessment of the company's expected consolidated net loss increase for the year ended 31 December 2017 compared to the previous year. The announcement explicitly states that the information is preliminary, not audited, and subject to adjustments. It advises caution to shareholders and investors. The document does not contain full financial statements or detailed financial analysis but serves as an early alert about expected financial performance. This type of document is typically classified as an Earnings Release (ER) because it announces key highlights of financial results before the full audited report is published. The document length is 4526 characters, which is short but contains substantive financial information rather than just a notice of report publication. Therefore, the appropriate classification is Earnings Release (ER). FY 2017
2018-01-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and related disclosures rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, consistent with disclosures required by stock exchanges for equity issuers. The document is not an annual or interim report, earnings release, or management discussion. It is not a proxy, AGM material, or voting result announcement. The detailed share capital movement data aligns with a Share Issue/Capital Change filing rather than a general regulatory announcement or other categories. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail support a confident classification.
2018-01-02 English
Inside Information
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to the Listing Rules of the Hong Kong Stock Exchange and the Securities and Futures Ordinance. It provides inside information about the removal of a coal-fired boiler due to government policy, the temporary suspension of production, and expected impacts on revenue. The document is relatively short (3407 characters) and serves as a regulatory disclosure of material operational information affecting the company, rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. It is not a report publication announcement since it contains substantive operational information. The nature of the announcement fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2017-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and related securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements rather than a financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2017-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2017. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements to the Hong Kong Exchanges and Clearing Limited. The document is not an annual or interim report, earnings release, or management discussion. It is a specific regulatory filing related to share capital movements and not a general regulatory announcement or report publication announcement. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length (over 14,000 characters) supports it being a substantive report rather than a brief announcement.
2017-11-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.